The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in low-resource regions. The collaboration enabled cost-effective, saliva-based ...

The Sepsis Diagnostics Market has emerged as a critical segment within the global healthcare and in-vitro diagnostics industry, driven by the urgent need for early disease detection and improved ...

Reducing Uncertainty in the Care and Treatment of Blood Cancer ST. LOUIS, MO, UNITED STATES, February 23, 2026 ...

Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four ...

On February 13, 2026, Mainz Biomed N.V. (the “Company”) entered into a securities purchase agreement for a 6.0 USD million private placement with investor David Lazar. The financing will be completed ...

LEX Diagnostics has secured the US FDA 510(k) clearance and CLIA waiver for its VELO system, a PCR point-of-care diagnostics platform for respiratory pathogens.

The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...

Veterinary Experimental and Diagnostic Pathology is a rapidly evolving field that has seen significant advancements in recent years. The discipline focuses on understanding the mechanisms of diseases ...